Earnings Labs
Kazia Therapeutics Limited logo

Kazia Therapeutics Limited (KZIA)

NASDAQ·Healthcare·Biotechnology

$11.98

+0.21%

Mkt Cap $13.31M

Analyst Ratings

No recent rating data.

Price Target (2 analysts)

$19.00

Range $18.00$20.00

Implied Upside

+58.7%

Consensus $19.00 vs current $11.98